Diagnostic efficacy was further assessed through ROC curve analysis, which yielded AUC values that suggested substantial diagnostic potential for IGF2BP2, YTHDC1, and WTAP in the NAFLD dataset (Fig 7D–7F). Here, IGF2BP2 is linked to metabolic dysfunction-associated steatotic liver disease.